HANLY ANN M. 4
4 · Vir Biotechnology, Inc. · Filed Feb 24, 2022
Insider Transaction Report
Form 4
HANLY ANN M.
EVP & Chief Technology Officer
Transactions
- Award
Common Stock
2022-02-22+53,500→ 84,100 total - Award
Stock Option (Right to Buy)
2022-02-22+47,000→ 47,000 totalExercise: $29.48Exp: 2032-02-21→ Common Stock (47,000 underlying)
Holdings
- 11.52(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]The shares are beneficially owned by the reporting person's spouse, for the benefit of a minor child.
- [F3]25% of the shares subject to the stock option vest and become exercisable on February 22, 2023, and the remainder vest in 36 equal monthly installments thereafter.